Efficacy and safety of generic glatiramer acetate Timexon®: results of the 12-month extension of BCD-063-1 international double-blind randomized placebo-controlled clinical study of efficacy and safety of Timexon® in comparison with Copaxone®

Author(s):  
Camila Tursunova
Sign in / Sign up

Export Citation Format

Share Document